PaxMedica, Inc. Common Stock PaxMedica, Inc. Common Stock

PaxMedica, Inc. Common Stock

PXMD

Rank in Stocks #34615
PaxMedica, Inc. is a biopharmaceutical company currently in the clinical... PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX-101, an intravenous (IV) form of suramin, which is being explored for a variety of conditions. These include autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, post-COVID-19 syndrome (commonly known as "long COVID"), and human African trypanosomiasis. Furthermore, PaxMedica is also developing PAX-102, an intranasal version of suramin, intended for various neurological applications. The company, which was incorporated in 2018 and has its headquarters in Tarrytown, New York, previously operated as Purinix Pharmaceuticals LLC before rebranding to PaxMedica, Inc. in April 2020. It functions as a subsidiary of Tardimed Sciences LLC.
Share Price
$0.0007
Last synced: 2026-11-11
Market Cap
$5.36K
Change (1 day)
0.00%
Change (1 year)
600.00%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade PaxMedica, Inc. Common Stock (PXMD)

Category

Healthcare
EPS for PaxMedica, Inc. Common Stock (PXMD)
EPS as of June 2024 TTM: $-6.89
According to PaxMedica, Inc. Common Stock's latest financial reports, its current EPS (TTM) is $-6.89. At the end of 2023 the company had an EPS of $-11.00, an increase over its 2022 EPS of $-28.73.
EPS history for PaxMedica, Inc. Common Stock from 2019 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-6.89 -37.36%
2023 $-11.00 -61.71%
2022 $-28.73 52.74%
2021 $-18.81 40.16%
2020 $-13.42 22,341.47%
2019 $-0.06 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -87.08%
US
$15.66 -327.29%
US
$-7.07 2.61%
US
$-5.29 -23.22%
AU
$12.73 -284.79%
BE

Questions about PaxMedica, Inc. Common Stock's earnings per share (EPS)

What is PaxMedica, Inc. Common Stock's earnings per share (EPS)?

PaxMedica, Inc. Common Stock's earnings per share (EPS) over the last twelve months is $-6.89, as of Jun 2024.

What was PaxMedica, Inc. Common Stock's earnings per share (EPS) in 2023?

In 2023, PaxMedica, Inc. Common Stock's earnings per share (EPS) was $-11.00, compared with $-28.73 in 2022.

How has PaxMedica, Inc. Common Stock's earnings per share (EPS) changed since 2019?

From 2019 to 2023, PaxMedica, Inc. Common Stock's earnings per share (EPS) was highest in 2019 ($-0.06) and lowest in 2022 ($-28.73).

How does PaxMedica, Inc. Common Stock's earnings per share (EPS) compare with similar companies?

PaxMedica, Inc. Common Stock's earnings per share (EPS) ($-6.89) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.